Damaged Kidneys ‘Poison’ the Heart, Leading to Heart Failure, Scientists Discover

More than half of individuals with chronic kidney disease (CKD) ultimately succumb to cardiovascular complications, but the precise mechanisms linking kidney damage to heart deterioration have remained elusive—until now. A groundbreaking study from UVA Health and Mount Sinai has identified a key culprit: damaged kidneys release tiny particles that actively harm the heart, accelerating the development of heart failure.

How Damaged Kidneys Harm the Heart

Researchers have discovered that diseased kidneys release circulating extracellular vesicles (EVs) containing genetic material—specifically, microRNA (miRNA)—that directly damages heart tissue. These EVs, normally involved in beneficial cellular communication, become carriers of toxic instructions when originating from failing kidneys.

“Kidney and heart disease can develop silently, so they are often discovered only after damage has already been done,” explains Uta Erdbrügger, MD, an internal medicine physician-scientist with the University of Virginia School of Medicine’s Division of Nephrology. “Our findings can help to identify patients at risk for heart failure earlier, enabling earlier treatment and improved outcomes.”

The Role of Extracellular Vesicles and miRNA

Extracellular vesicles are produced by almost all cells and typically function as messengers, transporting proteins and other materials between cells. Still, in the context of chronic kidney disease, these vesicles become vehicles for harmful genetic material. The specific miRNA they carry can accelerate the development of heart failure.

Evidence from both animal studies and analysis of human plasma demonstrated that blocking these EVs improved cardiac function in the presence of chronic kidney damage. Plasma analysis of human patients revealed significantly higher concentrations of these toxic particles in individuals with damaged kidneys compared to healthy volunteers.

Prevalence and Risk Factors

Chronic kidney disease affects more than 1 in 7 Americans—approximately 35 million people in the United States, according to the National Institutes of Health. The condition is particularly prevalent among individuals with diabetes (about 1 in 3 patients) and hypertension (about 1 in 5 people).

Previously, the link between CKD and cardiovascular disease was largely attributed to shared risk factors like obesity and high blood pressure, making it difficult to pinpoint a specific physiological cause. This research isolates a kidney-specific factor directly responsible for cardiac damage.

Future Implications and Diagnostic Potential

The discovery paves the way for the development of blood tests to detect these harmful extracellular vesicles, allowing for earlier identification of patients at risk of heart failure. Therapies aimed at blocking or neutralizing these EVs could likewise offer a new avenue for protecting the hearts of vulnerable patients.

“We showed that vesicles from the kidney can travel to the heart and be toxic,” Erdbrügger stated.

Researchers anticipate that these advances will lead to new biomarkers and personalized therapeutic options for kidney patients with cardiac risk, moving towards a more precise and tailored approach to medicine. The Paul and Diane Manning Institute of Biotechnology is playing a key role in translating these scientific discoveries into innovative therapeutic solutions.

Key Takeaways

• Damaged kidneys release particles that directly harm the heart.
• These particles, called extracellular vesicles, carry toxic genetic material (miRNA).
• The discovery explains why chronic kidney disease is a major risk factor for heart failure.
• New diagnostic tests and therapies are being developed to target these harmful particles.